591 filings
PRE 14A
GYRE
Gyre Therapeutics Inc
Preliminary proxy
19 Apr 24
4:06pm
S-8
GYRE
Gyre Therapeutics Inc
27 Mar 24
Registration of securities for employees
9:00pm
10-K
2023 FY
GYRE
Gyre Therapeutics Inc
Annual report
27 Mar 24
4:31pm
8-K
GYRE
Gyre Therapeutics Inc
26 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:03pm
8-K
GYRE
Gyre Therapeutics Inc
25 Mar 24
Gyre Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
9:55pm
8-K
238q4
21 Mar 24
Gyre Therapeutics Expands Board of Directors with Appointment of Rodney L. Nussbaum
7:15am
8-K
rxpqwoerrxw rrk
14 Feb 24
Results of Operations and Financial Condition
5:16pm
8-K/A
hqmneretp
19 Jan 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K/A
rw43mbxy1 549m727y3w
12 Jan 24
Completion of Acquisition or Disposition of Assets
4:01pm
8-K
433einkgkwpzc pk
15 Dec 23
Departure of Directors or Certain Officers
4:21pm
8-K
68lwk15wrrl2kn3
6 Dec 23
Regulation FD Disclosure
4:01pm
RW
6xlte35bi4j1 iq
29 Nov 23
Registration withdrawal request
4:01pm
8-K
3nkj12 q4faxs26lksp8
14 Nov 23
Regulation FD Disclosure
12:00am
D
9jfv5x1 i1tvgafp4j
13 Nov 23
$5.00 mm in equity / options, sold $5.00 mm, 1 investor
5:13pm
8-K
w3y0mzzu
13 Nov 23
Gyre Therapeutics Presents Poster at the American Association for the Study of Liver Diseases (AASLD) Annual Liver Meeting
7:01am
8-K
xpcvmkq2 im1
6 Nov 23
Regulation FD Disclosure
6:06am
8-K
yk476c6kvm33qer
2 Nov 23
Changes in Registrant's Certifying Accountant
5:00pm
424B3
ih8xnnjwf927
1 Nov 23
Prospectus supplement
5:18pm
S-8
jwpmf
30 Oct 23
Registration of securities for employees
5:46pm